GAS5 and cancer: In clinical samples of triple-negative breast cancer (TNBC), the most aggressive type of breast cancer, the expression of GAS5 was reduced in tumors, and a further decrease in the level of this lncRNA with increasing grade was observed in tumors of patients with metastases, late-stage cancer, and poor overall survival.